Brief: Anterogen receives patent
Oct 13 (Reuters) - Anterogen Co Ltd 065660.KQ :
* Says it receives a patent on Oct. 12, for Secretory
detection marker of proliferation and therapeutic potency of
adipocyte-derived stem cells and use thereof
* Patent number is 10-2013-0095562
Source text in Korean: https://goo.gl/ikYQ1j
Further company coverage: 065660.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Anterogen
See all newsBrief: S.Korea's Anterogen Says To Invest 3.8 Billion Won To Build New GMP Facility
Brief: Anterogen issues 3rd tranche convertible bonds worth 16 bln won
Brief: Anterogen to invest 7.1 bln won to set up central research institute and plant
Brief: Anterogen issues convertible bonds worth 18 bln won
Brief: Anterogen to issue 2nd series convertible bonds worth 18 bln won